InvestorsHub Logo

CrashOverride

02/21/22 10:14 AM

#445658 RE: Hspooner #445651

Management will soon be on Schadenfreude Tour 2022.

The Novocure pyramid scheme isn't a useful guide. They're not a standard of care treatment.

biosectinvestor

02/21/22 8:16 PM

#445709 RE: Hspooner #445651

Hard to know but I do not think institutions will pile in 1) until it is uplisted and 2) not at prices they consider too high. You’d need individuals and individuals on the OTC are mostly traders, and they are not reliable on the OTC. I don’t want to be a stick in the mud, no one really can know unless it happens, but I have been in enough companies on the OTC and shorted to know that you generally have to be very patient.